Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ALNY

Alnylam

$80.00

-2 (-2.44%)

08:43
10/16/18
10/16
08:43
10/16/18
08:43
Recommendations
Alnylam analyst commentary  »

Alnylam rolling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Nov

ABUS

Arbutus Biopharma

$4.14

-0.17 (-3.94%)

04:55
10/16/18
10/16
04:55
10/16/18
04:55
Upgrade
Arbutus Biopharma rating change at B. Riley FBR »

Arbutus Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Yesterday
ABUS

Arbutus Biopharma

$4.31

0.2 (4.87%)

07:34
10/15/18
10/15
07:34
10/15/18
07:34
Upgrade
Arbutus Biopharma rating change  »

Arbutus Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALNY

Alnylam

$82.00

2.51 (3.16%)

07:04
10/15/18
10/15
07:04
10/15/18
07:04
Hot Stocks
Alnylam announces plan to initiate rolling submission of NDA for givosiran »

Alnylam Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Nov

ABUS

Arbutus Biopharma

$4.31

0.2 (4.87%)

06:29
10/15/18
10/15
06:29
10/15/18
06:29
Upgrade
Arbutus Biopharma rating change at Wedbush »

Arbutus Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

, AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

05:18
10/15/18
10/15
05:18
10/15/18
05:18
Recommendations
Adamas Pharmaceuticals, Agios Pharmaceuticals, Alnylam, Alexion, Bluebird Bio, BioMarin, CymaBay, Crispr Therapeutics, Global Blood Therapeutics, Horizon Pharma, Jazz Pharmaceuticals, Ocular Therapeutix, Rigel Pharmaceuticals, Xencor analyst commentary at Piper Jaffray »

Piper lists names to own…

ADMS

Adamas Pharmaceuticals

$18.20

0.85 (4.90%)

AGIO

Agios Pharmaceuticals

$65.89

2.51 (3.96%)

ALNY

Alnylam

$82.00

2.51 (3.16%)

ALXN

Alexion

$121.91

2.62 (2.20%)

BLUE

Bluebird Bio

$125.92

-0.81 (-0.64%)

BMRN

BioMarin

$99.60

2.28 (2.34%)

CBAY

CymaBay

$10.19

0.19 (1.90%)

CRSP

Crispr Therapeutics

$37.74

0.85 (2.30%)

GBT

Global Blood Therapeutics

$33.01

1.46 (4.63%)

HZNP

Horizon Pharma

$18.27

0.23 (1.27%)

JAZZ

Jazz Pharmaceuticals

$158.82

3.42 (2.20%)

OCUL

Ocular Therapeutix

$6.09

-0.02 (-0.33%)

RIGL

Rigel Pharmaceuticals

$3.10

0.005 (0.16%)

XNCR

Xencor

$35.08

1.04 (3.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 19

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 07

    Nov

  • 27

    Nov

  • 01

    Dec

  • 20

    Dec

  • 28

    Dec

  • 18

    Feb

Friday
ALNY

Alnylam

$81.00

1.51 (1.90%)

10:09
10/12/18
10/12
10:09
10/12/18
10:09
Hot Stocks
Silence reports 'favorable' outcome of U.S. PTAB decision against Alnylam »

Silence Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Nov

Wednesday
AET

Aetna

$206.46

2.72 (1.34%)

, CVS

CVS Health

$80.24

0.67 (0.84%)

12:04
10/10/18
10/10
12:04
10/10/18
12:04
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AET

Aetna

$206.46

2.72 (1.34%)

CVS

CVS Health

$80.24

0.67 (0.84%)

TDG

TransDigm

$340.75

-10.63 (-3.03%)

ESL

Esterline

$115.11

26.36 (29.70%)

IMPV

Imperva

$55.10

12.07 (28.05%)

CLS

Celestica

$10.23

0.25 (2.51%)

KSS

Kohl's

$72.98

1.53 (2.14%)

ABUS

Arbutus Biopharma

$4.26

-1.77 (-29.35%)

TSE

Trinseo

$63.50

-12.64 (-16.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Oct

  • 15

    Oct

  • 16

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

Over a week ago
ABUS

Arbutus Biopharma

$6.29

-2.8 (-30.80%)

14:56
10/09/18
10/09
14:56
10/09/18
14:56
Downgrade
Arbutus Biopharma rating change at JMP Securities »

Arbutus Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

ABUS

Arbutus Biopharma

$8.12

-0.97 (-10.67%)

10:22
10/09/18
10/09
10:22
10/09/18
10:22
Downgrade
Arbutus Biopharma rating change at Wedbush »

Wedbush downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.